Cart
sales@molnova.com
Acetazolamide sodium
CAS No. 1424-27-7
Acetazolamide sodium( —— )
Catalog No. M35403 CAS No. 1424-27-7
Acetazolamide sodium (OT-302 sodium) is a potent carbonic anhydrase (CA)IX inhibitor with diuretic, antigonococcal, and antihypertensive activity and may be used for indications such as epilepsy, glaucoma, edema, and altitude sickness.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 37 | In Stock |
|
| 1G | 47 | In Stock |
|
Biological Information
-
Product NameAcetazolamide sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcetazolamide sodium (OT-302 sodium) is a potent carbonic anhydrase (CA)IX inhibitor with diuretic, antigonococcal, and antihypertensive activity and may be used for indications such as epilepsy, glaucoma, edema, and altitude sickness.
-
DescriptionAcetazolamide sodium is a carbonic anhydrase (CA) IX inhibitor with an IC50 of 30 nM for hCA IX. Acetazolamide sodium has diuretic, antihypertensive and anti-gonococcal activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic Anhydrase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1424-27-7
-
Formula Weight244.23
-
Molecular FormulaC4H5N4NaO3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 100 mg/mL (407.76 mM)DMSO : 100 mg/mL (407.76 mM; Ultrasonic )
-
SMILESO=C(C)NC1=NN=C(S(=O)([NH-])=O)S1.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bayat Mokhtari R, et al.Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma. BMC Cancer. 2017 Feb 24;17(1):156.?
molnova catalog
related products
-
Brinzolamide
Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor.
-
hCAI/II-IN-6
hCAI/II-IN-6 is a selective and orally active inhibitor of human carbonic anhydrase (CA). hCAI/II-IN-6 inhibited hCA I, hCA II, hCA VII, and hCA XII with Ki values of 220, 4.9, 6.5, and ＞50,000 nM.
-
EMAC10101d
compound EMAC10101d, bearing a 2,4-dichorophenyl substituent in position 4 of the dihydrothiazole ring, was the most potent and selective toward hCA II with an inhibitory activity in the low nanomolar range.
